Abstract
When the National Institutes of Health's study sections (peer review groups) meet this month to consider the latest sets of applications for NIH grants, they will be given a new task. In addition to ranking each proposal based on its scientific merit, the reviewers will be asked to pay particular attention to identifying studies that are both high risk and have the potential for a high return. Such proposals won't get a higher ranking than they otherwise would have, says Jerome G. Green, director of NIH's division of research grants. But they will be flagged as something unique. Then the NIH advisory councils—the committees that make the final decisions on which applications get funded—will have the option of giving the innovative applications special treatment. Green described the new targeting mechanism to a special session of the advisory council of the National Institute of General Medical Sciences (NIGMS). The group devoted a full afternoon last month ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
